The Pediatric Cardiomyopathy Registry: 1995-2007

Progress in Pediatric Cardiology

Volumn 25, Issue 1, 2008, Pages 31-36

  Wilkinson, James D ^a   Sleeper, Lynn A ^b   Alvarez, Jorge A ^a   Bublik, Natalya ^a   Lipshultz, Steven E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

Cardiomyopathy; Heart failure; Muscular dystrophy; Pediatric Cardiomyopathy Registry; Pediatric Cardiomyopathy Registry.

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; FAMILY HISTORY; FOLLOW UP; HEART FAILURE; HEART GRAFT; HEART MUSCLE BIOPSY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; LABORATORY TEST; MUSCULAR DYSTROPHY; NOONAN SYNDROME; PRIORITY JOURNAL; PROGNOSIS; UNITED STATES;

EID: 40949159750     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2007.11.006     Document Type: Article

References (10)

1. Grenier M.A., Osganian S.K., Cox G.F., et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 139 (2000) S86-S95
2. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. Jama 296 (2006) 1867-1876
3. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348 (2003) 1647-1655
4. Arola A., Jokinen E., Ruuskanen O., et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol 146 (1997) 385-393
5. Nugent A.W., Daubeney P.E.F., Chondros P., et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348 (2003) 1639-1646
6. Colan S.D., Lipshultz S.E., Lowe A.M., et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 115 (2007) 773-781
7. Cox G.F., Sleeper L.A., Lowe A.M., et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 118 (2006) 1519-1531
8. Kelley R.I., Cheatham J.P., Clark B.J., et al. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr 119 (1991) 738-747
9. Bione S., D'Adamo P., Maestrini E., Gedeon A.K., Bolhuis P.A., and Toniolo D. A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 12 (1996) 385-389
10. Schlame M., Towbin J.A., Heerdt P.M., Jehle R., DiMauro S., and Blanck T.J.J. Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome. Ann Neurol 51 (2002) 634-637